ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for ESPR

Stock NameEsperion Therapeutics Inc
TickerESPR(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS29664W1053
LEI549300OFU56UKEWVUS92

Show aggregate ESPR holdings

News associated with ESPR

HC Wainwright Reaffirms “Buy” Rating for Esperion Therapeutics (NASDAQ:ESPR)
HC Wainwright reiterated their buy rating on shares of Esperion Therapeutics (NASDAQ:ESPR – Free Report) in a report released on Friday,Benzinga reports. The firm currently has a $16.00 price target on the biopharmaceutical company’s stock. Separately, Wall Street Zen cut shares of Esperion Therapeutics from a “buy” rating to a “hold” rating in a research […] - 2025-09-22 03:10:44
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives $7.00 Consensus PT from Analysts
Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the five brokerages that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month […] - 2025-09-22 02:24:53
Esperion Therapeutics (NASDAQ:ESPR) Lowered to Hold Rating by Wall Street Zen
Wall Street Zen cut shares of Esperion Therapeutics (NASDAQ:ESPR – Free Report) from a buy rating to a hold rating in a report published on Monday morning. Other research analysts have also issued reports about the company. HC Wainwright reaffirmed a “buy” rating and set a $16.00 target price on shares of Esperion Therapeutics in […] - 2025-08-26 02:46:58
Esperion Therapeutics (NASDAQ:ESPR) Raised to “Buy” at Wall Street Zen
Esperion Therapeutics (NASDAQ:ESPR – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Sunday. A number of other research analysts have also weighed in on ESPR. HC Wainwright reiterated a “buy” rating and issued a $16.00 price objective on […] - 2025-08-19 02:58:51
Headlands Technologies LLC Sells 216,619 Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR)
Headlands Technologies LLC lowered its holdings in shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) by 84.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 38,447 shares of the biopharmaceutical company’s stock after selling 216,619 shares during the quarter. Headlands Technologies […] - 2025-08-13 05:22:53
Esperion Therapeutics (NASDAQ:ESPR) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Esperion Therapeutics (NASDAQ:ESPR – Free Report) from a sell rating to a hold rating in a report released on Saturday morning. Several other research firms also recently commented on ESPR. The Goldman Sachs Group reduced their price target on shares of Esperion Therapeutics from $4.00 to $3.00 and set […] - 2025-08-12 03:10:58
Analysts Set Esperion Therapeutics, Inc. (NASDAQ:ESPR) Price Target at $7.00
Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) have earned an average recommendation of “Moderate Buy” from the five brokerages that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average […] - 2025-08-05 04:30:55
Analysts Set Esperion Therapeutics, Inc. (NASDAQ:ESPR) Price Target at $7.00
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) has been given a consensus rating of “Moderate Buy” by the five ratings firms that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price […] - 2025-07-09 02:13:01
Investors Purchase Large Volume of Esperion Therapeutics Call Options (NASDAQ:ESPR)
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) was the recipient of unusually large options trading activity on Monday. Investors bought 2,720 call options on the company. This represents an increase of approximately 124% compared to the typical volume of 1,216 call options. Esperion Therapeutics Price Performance ESPR stock opened at $1.22 on Wednesday. The […] - 2025-06-11 02:06:51
Millennium Management LLC Sells 2,573,645 Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR)
Millennium Management LLC lowered its stake in Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) by 75.6% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 829,885 shares of the biopharmaceutical company’s stock after selling 2,573,645 shares during the period. Millennium Management LLC’s holdings in Esperion Therapeutics were worth $1,826,000 as of its most recent […] - 2025-06-03 04:34:55
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Shares Purchased by D. E. Shaw & Co. Inc.
D. E. Shaw & Co. Inc. grew its stake in shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) by 152.7% during the fourth quarter, Holdings Channel reports. The firm owned 251,592 shares of the biopharmaceutical company’s stock after purchasing an additional 152,019 shares during the period. D. E. Shaw & Co. Inc.’s holdings in […] - 2025-05-26 04:44:50
Gotham Asset Management LLC Trims Stock Position in Esperion Therapeutics, Inc. (NASDAQ:ESPR)
Gotham Asset Management LLC cut its stake in Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) by 49.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 11,977 shares of the biopharmaceutical company’s stock after selling 11,889 shares during the period. Gotham […] - 2025-05-22 05:34:52
MetLife Investment Management LLC Increases Holdings in Esperion Therapeutics, Inc. (NASDAQ:ESPR)
MetLife Investment Management LLC increased its stake in shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) by 65.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 117,732 shares of the biopharmaceutical company’s stock after buying an additional 46,682 shares during the period. MetLife Investment Management LLC’s holdings in Esperion Therapeutics were worth $259,000 […] - 2025-05-08 05:02:48
Invesco Ltd. Buys 13,101 Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR)
Invesco Ltd. increased its position in shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) by 15.5% during the fourth quarter, Holdings Channel reports. The institutional investor owned 97,833 shares of the biopharmaceutical company’s stock after purchasing an additional 13,101 shares during the period. Invesco Ltd.’s holdings in Esperion Therapeutics were worth $215,000 as of […] - 2025-05-05 05:00:55
XTX Topco Ltd Reduces Stock Position in Esperion Therapeutics, Inc. (NASDAQ:ESPR)
XTX Topco Ltd trimmed its holdings in Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) by 84.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 24,494 shares of the biopharmaceutical company’s stock after selling 131,806 shares during the period. XTX Topco Ltd’s holdings […] - 2025-05-01 05:28:55
Analysts Set Esperion Therapeutics, Inc. (NASDAQ:ESPR) PT at $6.42
Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the six brokerages that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, one has given a hold rating and four have issued a buy rating […] - 2025-04-25 02:10:49

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) ESPR holdings

DateNumber of ESPR Shares HeldBase Market Value of ESPR SharesLocal Market Value of ESPR SharesChange in ESPR Shares HeldChange in ESPR Base ValueCurrent Price per ESPR Share HeldPrevious Price per ESPR Share Held
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ESPR by Blackrock for IE00BYXG2H39

Show aggregate share trades of ESPR

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-06BUY1,0203.1203.420 3.390USD 3,458 1.59
2025-10-03BUY2,3803.3003.380 3.372USD 8,025 1.58
2025-10-02BUY3402.9002.940 2.936USD 998 1.57
2025-09-30BUY6802.6502.710 2.704USD 1,839 1.56
2025-09-26BUY6822.6502.650 2.650USD 1,807 1.54
2025-09-25BUY6822.5602.600 2.596USD 1,770 1.54
2025-09-24SELL-13,3192.4302.510 2.502USD -33,324 1.53 Loss of -12,908 on sale
2025-09-18BUY3832.7502.800 2.795USD 1,070 1.53
2025-09-17BUY1,1522.7202.850 2.837USD 3,268 1.52
2025-09-11SELL-3812.7902.800 2.799USD -1,066 1.49 Loss of -499 on sale
2025-09-10BUY7642.6002.600 2.600USD 1,986 1.48
2025-09-05SELL-3802.6802.710 2.707USD -1,029 1.46 Loss of -473 on sale
2025-08-29SELL-1,1522.2202.280 2.274USD -2,620 1.44 Loss of -958 on sale
2025-08-27BUY7642.1802.240 2.234USD 1,707 1.43
2025-08-26SELL-3822.1902.230 2.226USD -850 1.43 Loss of -305 on sale
2025-08-25BUY3822.1502.290 2.276USD 869 1.42
2025-08-20SELL-1,5202.0502.090 2.086USD -3,171 1.42 Loss of -1,019 on sale
2025-08-18BUY7562.1002.110 2.109USD 1,594 1.41
2025-08-08SELL-7581.8701.880 1.879USD -1,424 1.39 Loss of -370 on sale
2025-08-05BUY3791.6201.720 1.710USD 648 1.38
2025-08-01SELL-1,1341.4001.420 1.418USD -1,608 1.38 Loss of -41 on sale
2025-07-30BUY22,4421.4101.520 1.509USD 33,865 1.38
2025-07-17SELL-6421.2401.270 1.267USD -813 1.38 Profit of 75 on sale
2025-07-11SELL-2,5921.1901.240 1.235USD -3,201 1.39 Profit of 403 on sale
2025-07-07BUY9721.1101.180 1.173USD 1,140 1.40
2025-07-02BUY17,7101.1501.180 1.177USD 20,845 1.40
2025-06-25BUY6441.0101.080 1.073USD 691 1.42
2025-06-11BUY6441.2101.240 1.237USD 797 1.44
2025-06-10BUY6441.2201.240 1.238USD 797 1.44
2025-06-04SELL-3221.1201.130 1.129USD -364 1.45 Profit of 105 on sale
2025-04-23BUY3220.9501.060 1.049USD 338 1.68
2025-04-10SELL-2,5760.9601.040 1.032USD -2,658 1.78 Profit of 1,933 on sale
2025-04-08SELL-3221.0601.250 1.231USD -396 1.81 Profit of 185 on sale
2025-04-07SELL-3221.2001.230 1.227USD -395 1.81 Profit of 189 on sale
2025-04-04SELL-1,6101.2301.300 1.293USD -2,082 1.82 Profit of 855 on sale
2025-04-01BUY1,2881.4101.460 1.455USD 1,874 1.84
2025-03-31SELL-9661.4401.490 1.485USD -1,435 1.84 Profit of 348 on sale
2025-03-14SELL-5,1681.5001.580 1.572USD -8,124 1.90 Profit of 1,683 on sale
2025-03-07SELL-6461.6901.710 1.708USD -1,103 1.94 Profit of 147 on sale
2025-03-04SELL-3231.7701.860 1.851USD -598 1.96 Profit of 34 on sale
2025-02-25BUY6461.7301.860 1.847USD 1,193 2.00
2025-02-19SELL-3231.9001.930 1.927USD -622 2.02 Profit of 29 on sale
2025-02-13BUY9691.8701.910 1.906USD 1,847 2.04
2025-02-12BUY3231.8801.900 1.898USD 613 2.05
2025-02-11BUY1,2921.7901.840 1.835USD 2,371 2.06
2025-01-17BUY1,2842.2102.310 2.300USD 2,953 2.23
2025-01-16BUY1,2842.2602.280 2.278USD 2,925 2.23
2025-01-10SELL-6422.3402.360 2.358USD -1,514 2.18 Loss of -114 on sale
2025-01-08SELL-1,2922.1702.190 2.188USD -2,827 2.20 Profit of 16 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ESPR

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-192,088,72510,2964,599,81045.4%
2025-09-181,491,44933,2183,429,13243.5%
2025-09-17703,7001002,388,46729.5%
2025-09-161,359,7059,3102,747,79649.5%
2025-09-151,427,5579943,094,21546.1%
2025-09-12650,8685002,438,29926.7%
2025-09-11876,72712,5983,837,13022.8%
2025-09-10969,67584,0313,386,32528.6%
2025-09-09795,29242,8965,747,11213.8%
2025-09-081,614,70617,7005,904,19827.3%
2025-09-052,092,2223006,131,79734.1%
2025-09-041,767,45904,271,30041.4%
2025-09-03843,0602,5003,648,65923.1%
2025-09-02755,6291,5004,161,75718.2%
2025-08-292,013,3059373,966,93550.8%
2025-08-28584,06702,290,10325.5%
2025-08-27547,0105,0002,301,03723.8%
2025-08-26492,39302,034,80624.2%
2025-08-25836,50702,698,47031.0%
2025-08-22367,64810,6002,566,30114.3%
2025-08-21332,9543,2192,291,85814.5%
2025-08-20495,0464,8542,139,05923.1%
2025-08-19472,1311,5112,243,60521.0%
2025-08-18733,4582222,819,68426.0%
2025-08-15843,0876,7303,004,92328.1%
2025-08-14813,26222,1123,922,58420.7%
2025-08-131,333,8332,7975,077,77026.3%
2025-08-12824,9014,0002,728,29530.2%
2025-08-11616,67802,501,98724.6%
2025-08-08575,3193,3213,166,84818.2%
2025-08-07706,058113,110,35522.7%
2025-08-061,600,39322,8145,387,02729.7%
2025-08-051,522,91724,4614,628,14532.9%
2025-08-04546,13502,361,17923.1%
2025-08-01534,75601,445,62037.0%
2025-07-31677,49001,850,60836.6%
2025-07-30921,9481,3202,623,50435.1%
2025-07-291,233,89514,5632,950,23541.8%
2025-07-281,449,5334783,670,37939.5%
2025-07-251,271,76141,4752,911,21443.7%
2025-07-246,183,03894,91318,475,23533.5%
2025-07-23953,19662,8463,294,35428.9%
2025-07-22473,3224,7251,358,56034.8%
2025-07-21321,78301,107,86429.0%
2025-07-18361,3593,4501,426,46725.3%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy